Abbott Laboratories hit a new 52-week high, surpassing its previous peak of $136.99, which the company achieved on February ...

Abbott Laboratories (NYSE:ABT) shares closed flat at $135.87 on Thursday, after gaining for six straight sessions. The ...

Abbott Laboratories's ABT short percent of float has risen 21.7% since its last report. The company recently reported that it ...

Gregg LoCascio, Michael Glick, Tracie Bryant and their team at Kirkland & Ellis secured a defense verdict in California state ...

Abbott Laboratories (NYSE:ABT) discovers, develops, manufactures and sells healthcare products worldwide. It is set to report ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Furthermore, you'd generally like to see the share price rise faster than the market. But Abbott Laboratories (NYSE:ABT) has fallen short of that second goal, with a share price rise of 75% over ...

Key Insights Significantly high institutional ownership implies Abbott Laboratories' stock price is sensitive to ...

A new awareness campaign from Abbott highlights a major sticking point in diabetes management: the harmful impact of societal ...